Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries (Q37944318)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

gastroenteritis

1 reference

based on heuristic

inferred from title

rotavirus vaccine

1 reference

based on heuristic

inferred from title

1

object named as

Greg L Plosker

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

publication date

1 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

989-1009

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Global Illness and Deaths Caused by Rotavirus Disease in Children

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus gastroenteritis.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Vaccines for rotavirus gastroenteritis universally needed for infants

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Burden of rotavirus disease in European Union countries

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus infections and vaccines: burden of illness and potential impact of vaccination

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus and severe childhood diarrhea

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Protective effects of natural rotavirus infection

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countries.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus infection in infants as protection against subsequent infections

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus vaccine RIX4414 (Rotarix): a review of its use in the prevention of rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Global mortality associated with rotavirus disease among children in 2004.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

The epidemiology of human rotavirus associated with diarrhoea in Kenyan children: a review

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Sentinel hospital surveillance for rotavirus in latin american and Caribbean countries

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus vaccine introduction in the Americas: progress and lessons learned

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Multicenter prospective study on the burden of rotavirus gastroenteritis in Turkey, 2005-2006: a hospital-based study

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus diarrhea disease burden in Peru: the need for a rotavirus vaccine and its potential cost savings

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Hospital Health Care Cost of Diarrheal Disease in Northern Ghana

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus epidemiology: the Asian Rotavirus Surveillance Network.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Seasonality of rotavirus disease in the tropics: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Decline in Rotavirus Hospitalizations and Health Care Visits for Childhood Diarrhea Following Rotavirus Vaccination in El Salvador

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

The cost-effectiveness of rotavirus vaccination in Malawi

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Cost-effectiveness of rotavirus vaccination in peru

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Economic impact of a rotavirus vaccination program in Mexico.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Projected cost-effectiveness of rotavirus vaccination for children in Asia

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Potential cost-effectiveness of a rotavirus immunization program in rural China

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Cost-effectiveness analysis of routine rotavirus vaccination in Brazil.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Cost-effectiveness of Rotavirus vaccination in Vietnam

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Economic evaluation of a routine rotavirus vaccination programme in Indonesia

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Health and economic impact of rotavirus vaccination in GAVI-eligible countries

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Safety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implications

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Incorporating herd immunity effects into cohort models of vaccine cost-effectiveness

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Real-world impact of rotavirus vaccination

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Economic evaluations of rotavirus immunization for developing countries: a review of the literature.

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Effectiveness of Monovalent Rotavirus Vaccine (Rotarix) against Severe Diarrhea Caused by Serotypically Unrelated G2P[4] Strains in Brazil

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Rotavirus vaccination in northeast Brazil: A laudable intervention, but can it lead to cost-savings?

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

The Clinical Burden of Rotavirus Disease

1 reference

https://api.crossref.org/works/10.2165%2F11207210-000000000-00000

21 January 2018

Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory syncytial virus activity-- United States, July 2007-December 2008.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic impact of a rotavirus vaccine in Brazil

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Climatic factors associated with hospitalizations for rotavirus diarrhoea in children under 5 years of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human infection with new influenza A (H1N1) virus: Mexico, update, March-May 2009

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meeting of the immunization Strategic Advisory Group of Experts, April 2009--conclusions and recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of rotavirus vaccination on discounted net tax revenue in Egypt: a government perspective analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resource utilization and costs of treating severe rotavirus diarrhea in young Mexican children from the health care provider perspective.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is there a role for pharmacoeconomics in developing countries?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reaching MDG 4 in India: A Role for Rotavirus Vaccine?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rotavirus vaccine--AVANT immunotherapeutics/GlaxoSmithKline: 89-12, RIX4414

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rotavirus vaccines:an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease and economic burden of rotavirus diarrhoea in India

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of vaccination programs: the impact of herd-immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defeating rotavirus? The global recommendation for rotavirus vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of influenza

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is There a Role for Pharmacoeconomics in Developing Countries?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccines for preventing rotavirus diarrhoea: vaccines in use

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea

1 reference

https://pubmed.ncbi.nlm.nih.gov/21988293

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11207210-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37944318&oldid=2201099215"